BACKGROUND: The FINE-CKD model was developed to estimate the cost-effectiveness of finerenone in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). OBJECTIVE: To perform internal ...
Alexandra Twin has 15+ years of experience as an editor and writer, covering financial news for public and private companies. Investopedia / Zoe Hansen Overfitting occurs when a model is too closely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results